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Streptococcus pneumoniae (SPN; pneumococcus) accounts for 50% of bacterial meningitis in humans. This often devastating infection car ries a 30% mortality rate, and up to half of survivors experience neurological sequelae reflecting a wide spectrum of brain injuries, including cortical neuronal necrosis and hippo campal neuronal apoptosis (Koedel et al., 2002; van de Beek et al., 2004; Weisfelt et al., 2006; Weber and Tuomanen, 2007) . To cause meningitis, bloodborne bacteria must first at tach to and penetrate human brain micro vascular endothelial cells (hBMECs), which is the singlecell layer comprising the majority of the blood-brain barrier (BBB; Tuomanen, 1996; Kim, 2003) . The molecular mecha nisms underlying the distinct central nervous system (CNS) tropism of SPN are poorly un derstood. All SPN clinical isolates express the surfaceanchored sialidase (neuraminidase) NanA (Cámara et al., 1994; Pettigrew et al., 2006) that targets sialic acid residues on host cells and bacterial flora to promote SPN mucosal colonization (Shakhnovich et al., 2002; Tong et al., 2002) . Here, we use an isogenic SPN NanAdeficient mutant and heterologous expression of the NanA constructs to probe the contribution of this protein to SPN hBMEC interactions in vitro and BBB pene tration in vivo.
RESULTS AND DISCUSSION SPN NanA mutant and heterologous expression of NanA in Lactococcus lactis
NanA is a molecule of 1,035 amino acids and 107 kD molecular mass containing a Cter minal LP(X)TG anchor motif for sortase mediated anchoring to the SPN cell wall NanA is necessary and sufficient to promote hBMEC adherence and invasion Studies of microbial interactions with the human BBB have been greatly facilitated by the development of an im mortalized hBMEC line retaining the morphological and functional characteristics of primary endothelium (Kim, 2006) . Adherence and intracellular invasion of hBMEC within a membranebound vacuole appears to be a common phenotypic property of several CNS bacterial pathogens, including SPN (Ring et al., 1998) , group B Streptococcus (Nizet et al., 1997) , Escherichia coli K1 (Huang et al., 1995) , and Haemophilus influenzae (Orihuela et al., 2009) . Using an in vitro assay, we found the SPN NanA mutant to exhibit a >90% decrease in hBMEC adherence and inva sion compared with the WT parent strain D39, a defect that was corrected upon complementation of the mutant with NanA on a plasmid vector (Fig. 1 D; P < 0.001). Conversely, heterologous expression of SPN NanA in L. lactis conferred a >10fold increase in the bacterium's ability to adhere to and invade the cultured hBMEC (Fig. 1 E ; P < 0.001).
A sialidase inhibitor does not fully block NanA-dependent hBMEC invasion To further dissect the roles of SPN NanA and its enzy matic activity in mediating pneumococcal interactions (Lock et al., 1988; Cámara et al., 1994) . NanA sialidase ac tivity targets at least three linkage classes of substrates: the 2,6 and 2,3 linkages of Nacetylneuraminic acid to galactose and the 2,6 linkages of Nacetylneuraminic acid to Nacetylgalactosamine (Scanlon et al., 1989) . To investigate the potential contribution of NanA to SPN in teractions with the BBB endothelium, we compared the wellcharacterized serotype 2 strain clinical isolate D39, which was originally isolated by Avery in 1916 (Avery et al., 1944 and is highly virulent in animal infection models (Lanie et al., 2007) , to its isogenic mutant NanA, which is confirmed to possess a targeted nonpolar mutation that eliminates NanA expression (Winter et al., 1997) . Using a fluorescent assay, we found the NanA mutant to lack siali dase activity present in the WT parent strain D39 (Fig. 1 A) . For complementation and gainoffunction analyses, we amplified the NanA gene from the D39 chromosome, cloned it into an expression vector to generate the recom binant plasmid pNanA, and used this to transform the SPN NanA mutant and nonpathogenic Grampositive bacte rium L. lactis, confirming NanA surface expression by flow cytometry in the latter (Fig. 1 B) . Complementation in trans with NanA restored sialidase activity to the SPN NanA mutant (Fig. 1 A) . Furthermore, compared with the empty vector control, pNanA conferred significant sialidase activ ity to L. lactis (Fig. 1 C) . 
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Exogenous sialidase treatment modestly enhances NanA-dependent hBMEC invasion Addition of exogenous sialidase (from Arthrobacter ureafaciens) failed to rescue the adherence and invasion defects of the SPN NanA mutant, and did not stimulate L. lactis hBMEC interactions in the absence of NanA (Fig. 2, A and B) . How ever, for SPN or L. lactis-expressing NanA, exogenous siali dase stimulated a modest (20-30%), but statistically significant, increase in hBMEC adherence and invasion (Fig. 2, A and B) . These results indicate that SPN NanA is both necessary and sufficient to promote efficient bacterial hBMEC adherence and invasion, and suggest that this phenotype is enhanced by, but not dependent on, the sialidase activity of the surface bound protein.
with hBMEC, we used the broadspectrum sialidase inhibitor 2deoxy2,3dehydroNacetylneuraminic acid (Neu5Ac2en; Holzer et al., 1993) . Neu5Ac2en treatment resulted in a dosedependent inhibition of NanA sialidase activity with maximal inhibition reaching a plateau between 2.5 and 10 mM (Fig. 2 A) . Neu5Ac2en reduced, but did not eliminate, NanAdependent adherence and invasion of hBMECs in both the SPN (Fig. 2, B and C) and L. lactis (Fig. 2 D) backgrounds. In contrast, the Neu5Ac2en in hibitor had no effect on the lowlevel baseline hBMEC interactions present in bacteria lacking NanA (Fig. 2, C and D). These findings support a significant contribution of NanA to hBMEC invasion that is independent of its enzymatic activity. Second, SPN NanA belongs to a superfamily of concavalin A-like glucanases, including the Vibrio cholerae sialidase (Crennell et al., 1994) and the Trypanasoma cruzi transsialidase (Buschiazzo et al., 2002) , which contain a sialic acid cleavage domain and a second "lectinlike domain." Because the sialidase activity of NanA is hypothesized to promote SPN colonization by modulating carbohydrate moieties on epithelial cell surfaces and exposing higher affinity receptors (Tong et al., 2002; King et al., 2006) , it is conceivable that a NanA lectinlike domain, if indeed functional in promoting binding, could work together with its enzymatic activity in mediating host cell interactions. This laminin Glike domain of NanA is sit uated toward the N terminus, and we generated a deletion derivative of pNanA lacking this domain, pNanAlect (Fig. 3 A) . When pNanAlect was used to complement the SPN NanA mutant, WT levels of both surface protein Relative contributions of NanA enzyme active site and Nterminal lectinlike domain in pneumococcal hBMEC invasion Two targeted deletions were constructed in the recombinant NanA protein and cloned into expression plasmids (Fig. 3 A) . These plasmids were then reintroduced by complementation into the SPN NanA mutant to determine the consequences of each deletion on NanAmediated hBMEC interactions. First, active site residues essential for the sialidase activity of SPN NanA have recently been identified , and we deleted a region containing two of these resi dues (Glu647 and Arg663) from pNanA to yield the deriva tive plasmid, pNanAenz (Fig. 3 A) . When pNanAenz was used to complement the NanA mutant, surface expression of the protein was restored to WT levels as assessed by flow cytometry (Fig. 3 B) , but, as expected, this expression was not associated with detectable sialidase activity (Fig. 3 C) . (A) Scheme for deletion of active site residues and lectinlike domain from recombinant SPN NanA protein; position of protein fragment 318-792 used in subsequent studies. (B) Expression of mutant NanA protein constructs similar to that of NanA on the WT SPN surface as detected by flow cytometry using a rabbit polyclonal antisera against protein fragment 318-792. (C) Deletion of active site region eliminates NanA-induced sialidase activity in L. lactis, whereas deletion of the NanA lectinlike domain has no effect. (D) Targeted elimination of either the NanA enzymatic activity or the N-terminal lectinlike domain allows only partial complementation of the defect in hBMEC adherence, invasion, or transcytosis of the NanA mutant versus WT SPN. Sialidase and transcytosis assays were performed three times with similar results; representative experiment shown. Adherence and invasion assays were performed in triplicate and repeated at least three times; graphs show cumulative data from all experiments. Error bars represent standard deviation, statistical analysis by analysis of variance with multiple pairwise comparisons.
BRIEF DEFINITIVE REPORT the brain endothelium. Consistent with this model, addition of rabbit polyclonal antisera raised against the same recom binant NanA protein fragment also produced a concentra tiondependent inhibition of SPN hBMEC adherence and invasion (Fig. 4 B) .
NanA promotes SPN-BBB interaction in vivo
Lastly, we sought to determine whether the marked contri bution of SPN NanA to hBMEC adherence and invasion in vitro translated to increased capacity of SPN to penetrate the BBB in vivo. Our choice of animal model had to exclude the confounding contribution of NanA to sustained bacteremia because a NanAdeficient SPN mutant was recently found to be cleared from the mouse circulation within 24 h of intrave nous challenge, whereas the WT parent strain proliferated (Manco et al., 2006) . To focus specifically on SPN-BBB interactions, we developed a shortterm (4h) murine intra venous challenge model that incorporated terminal exsangui nation by saline perfusion (to eliminate blood contamination), allowing calculation of the ratio of SPN CFU in brain versus blood at the experimental endpoint. We found that at 4 h, the levels of WT D39 and isogenic NanA mutant SPN in blood were similar, but the median ratio of brain/blood CFU in the WT strain (0.512%) was 16fold greater than the NanA mutant (0.031%; P < 0.01; Fig. 5 A) . Histopathologic expression (Fig. 3 B) and sialidase enzymatic activity (Fig. 3 C) were restored.
The NanA mutant strains complemented with pNanA, pNanAEnz or pNanALec were tested in the hBMEC in vasion and adherence assays, as well as for their ability to transcytose across a polar hBMEC monolayer from the lumi nal to basolateral side (Fig. 3 D) . In contrast to the full resto ration of WT levels of adherence and invasion achieved by complementation with a WT NanA expression plasmid (Fig. 1 D) , the pNanAEnz yielded only partial complemen tation of the phenotypes, to 50% WT levels (Fig. 3 D) . On statistical analysis, these intermediate levels of hBMEC ad herence, invasion, and transcytosis were significantly greater than those observed for the NanA mutant, although signifi cantly less than those observed for the WT parent strain or the mutant complemented with the intact NanA protein (Fig. 3 D) . Thus, NanA sialidase enzymatic activity makes a small, but still demonstrable, contribution to these pneumo coccal-hBMEC interactions, which is consistent with the modest effects of sialidase inhibition or exogenous sialidase treatment (Fig. 2, A-F) . In contrast, only a very small increase in adherence, invasion, or transcytosis was detected when the NanA mutant was complemented with pNanALec (to 20% WT levels), and this did not achieve statistical signifi cance when compared with the same mutant transformed with empty vector control. Moreover, the pNanALec complemented mutant was significantly less adherent and in vasive than the pNanAEnzcomplemented strain (P < 0.001; Fig. 3 D) . These data reveal a clear role of the Nter minal lectinlike domain in NanAmediated pneumococcal hBMEC interactions. The dual functionality of pneumococ cal NanA in sialic acid cleavage and promotion of host cell binding draws analogy to the activities of T. cruzi transsialidase, a virulence factor that can bind to lymphocytes, neurons, and heart endothelial cells to stimulate important host cell activa tion and proliferation phenotypes (Saavedra et al., 1999; Chuenkova and Pereira, 2000; Gao et al., 2002; Chuenkova and PereiraPerrin, 2004) .
NanA peptide or anti-NanA antibody inhibits SPN hBMEC adherence and invasion
The ability of NanA to promote a level of SPN hBMEC ad herence and invasion even in the absence of its sialidase activ ity suggested the protein also serves directly as an adhesin/invasin moeity for the hBMEC surface or can stimulate an upregu lation of hBMEC processes that promote bacterial uptake in dependent of binding. To further probe these possibilities, an exogenous NanA protein fragment (amino acids 318-792, including key active site residues but lacking sialidase activity) was added to the adherence and invasion assays to determine if its presence blocked or stimulated SPNhBMEC interac tions. We found a dosedependent inhibition of SPN adher ence and invasion of hBMEC by the recombinant NanA protein fragment (Fig. 4 A) , which is consistent with a com petitive inhibition of cellular receptor(s), suggesting that SPN NanA can function in the capacity of an adhesin/invasin for clinical correlation between the magnitude of free sialic acid levels in cerebrospinal fluid during pneumococcal meningitis and risk of adverse neurological sequelae including coma has been reported (O'Toole et al., 1971) .
Loss of two additional SPN surface proteins has been previously associated with diminished invasion and trans cytosis of cultured hBMEC cells-the fibronectinbinding protein PavA and cholinebinding protein A (CbpA; Ring et al., 1998; Pracht et al., 2005) . Operating in the context of the low capsule, "transparent" phase variant phenotype of SPN, CbpA binds the laminin receptor to promote hBMEC adhesion. In concert, CpbA presents SPN cell wall phosphorylcholine that attaches to plateletactivating factor receptor on the hMBEC surface, promoting in vasion (Ring et al., 1998) . Although the highcapsule, "opaque" phenotype of SPN predominates in the blood stream (transparent forms are readily phagocytosed), the highfrequency switch between the two phase variants is sufficient to reveal a contribution of CbpA to BBB pene tration in vivo (Orihuela et al., 2004) . The studies of NanA reported in the present manuscript were all performed with inocula of SPN expressing the opaque phenotype. We propose that NanA and CpbA may function synergis tically to promote passage of the phasevariant SPN bacte rium across the BBB.
analysis and tissue Gramstain could identify lancetshaped diplococci associated with brain endothelium in sections from WTinfected mice; CNSassociated bacteria were scant or absent in those animals infected with the isogenic NanA mutant (Fig. 5 B) .
Role of NanA in SPN-BBB interactions and the development of meningitis
We conclude that NanA plays an important role in the SPN invasion of BBB endothelial cells and bacterial entry into the CNS, the critical first step in the pathogenesis of meningitis. The contribution of SPN NanA to hMBEC invasion involves an adhesin function, in which the Nterminal lectinlike do main plays a critical role, and a small but significant contribu tion of the sialidase activity, which may modify host cell receptors to reveal higher affinity ligands, as previously hy pothesized for NanA in nasal colonization (King et al., 2006) . After SPN breeches the BBB endothelium, subsequent brain injury is more likely the byproduct of different SPN virulence determinants (e.g., the poreforming toxin pneumolysin; Braun et al., 2002) or host factors, as previous studies using di rect intracerebral installation of SPN in mice or guinea pigs identified no differences between WT and NanA mutant in meningeal inflammation, hearing loss, or neuronal injury scores (Winter et al., 1997; Wellmer et al., 2002) . Nevertheless, a Comparison of bacterial counts (CFU) recovered from the blood and brain of mice 4 h after intravenous challenge with 5 × 10 7 CFU of WT SPN strain D39 or its isogenic NanA mutant. Results represent a single large experiment with n = 8 per group; all data shown. Because of the technically challenging complete saline perfusion before brain harvesting, individual mouse infections were initiated at staggered timed, with validation of bacterial inocula throughout by CFU counts. Although blood CFU recovered at 4 h did not differ between the two groups (P = 0.37), the ratio of brain CFU/blood CFU in individual mice was significantly higher in mice infected with the WT SPN strain than the NanA mutant (P < 0.01). Statistics by Student's t test; red line shows median. A repeat experiment performed without saline perfusion and using a 6-h time point yielded similar results (Fig. S1). (B) Representative histopathological examination (100× oil immersion) of brain from WT SPNinfected mice showed Gram-positive cocci in association with brain microvascular endothelium or within the brain parenchyma (arrows); such findings were extremely rare or absent in animals infected with the NanA mutant. Bar, 15 µM.
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360 nm, emission 460 nm) was recorded every 15 min from time 0 to 1 h, with reported values corrected for the reaction blank containing phosphate citrate buffer alone. hBMEC assays. Immortalized hBMEC line hBMEC, a product of SV40 large T antigen transformation maintaining the morphological and func tional characteristics of primary endothelium, was obtained from K.S. Kim (Johns Hopkins University, Baltimore, MD). hBMECs were maintained in RPMI 1640 medium (Life Tech Technologies, Inc.) supplemented with 10% FBS, 10% NuSerum (BD), and 1% MEM nonessential amino acids, and were incubated at 37°C in 5% CO 2 . Bacterial adherence and invasion assays were performed essentially as previously described (Doran et al., 2005) within 24 h of established confluence (10 5 cells/well) at multiplicity of infection = 10 bacteria/cell and duration 30 min (adherence assays) or 2 h (invasion assays). For a transcytosis assay, hBMEC were grown to conflu ence on collagencoated 3 µM pore size Transwell plates (CorningCostar); 5 × 105 CFU of logphase SPNs were added to the upper (luminal) cham ber, and CFU reaching the lower chamber enumerated at the 4h time point. For inhibition studies, a recombinant NanA protein fragment (resi dues 318-792) at 2.5 or 5.0 µg/well or antiNanA rabbit polyclonal antisera at 1:250 or 1:500 final dilution were added to the adherence and invasion assays as indicated; controls for these experiments were bovine serum albu min (5.0 µg/well) and rabbit polyclonal antihyaluronidase antisera (1:250 dilution), respectively.
Murine model of SPN brain endothelial cell invasion. 8-10 wk old male BALB/c mice were injected intravenously with 5 × 10 7 CFU of SPN D39 or its isogenic D39NanA mutant. 4 h after injection, blood was col lected and serial dilutions plated to enumerate bacterial CFU in the circula tion. Mice were then deeply anesthesized using an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). Their chests were opened, and blood was cleared by inserting a 23gauge needle into the left ventricle, perfusing with sterile PBS for 7 min using a peristaltic perfusion pump (P1; GE Healthcare), and allowing fluid to exit through the right atrium. After perfusion, brains were removed and the hemispheres were separated. One half of the brain was homogenized in PBS, diluted, and plated on THY agar plates to enumerate bacteria tightly adherent to the BBB; the other half was fixed in PBS + 4% PFA for histopathological analysis. A repeat mouse challenge experiment was performed as above, omitting the perfusion step, and using a 6h rather than 4h experimental endpoint.
Assurances. All animal experiments were approved by the University of California, San Diego (UCSD) Committee on the Use and Care of Animals and performed using accepted veterinary standards. The UCSD Biosafety Committee approved all protocols for bacteriologic experiments.
Online supplemental material. Fig. S1 is a repeat intravenous mouse challenge of WT SPN versus isogenic NanA mutant to quantify bac terial entry into the brain compared with bacterial levels in the blood. This experiment represents a replicate of the study shown in Fig. 5 , but omitting the saline perfusion step and using 6 h rather than 4 h end point. Online supplemental material is available at http://www.jem.org/ cgi/content/full/jem.20090386/DC1. The conservation of NanA expression in all clinical iso lates of SPN prompted interest in the recombinant protein as a universal vaccine antigen against this leading pathogen (Tong et al., 2005; Yesilkaya et al., 2006) , as current conju gate polysaccharide vaccines only target a subset of the most common SPN serotypes. Our identification of NanA func tion in hBMEC adherence and invasion suggests such immunization strategies could have an added benefit in re ducing the risk of meningitis as a secondary complication of invasive infection.
MATERIALS AND METHODS
Bacterial strains and preparation of inocula. SPN serotype 2 strain D39 (NCTC 7466) and its isogenic D39NanA mutant were used for these ex periments. D39NanA was constructed by nonpolar insertionduplication mutagenesis of the nanA gene, as previously described (Winter et al., 1997) . SPN cultures were grown in ToddHewitt broth (THB) + 2% yeast extract (THY media). For complementation studies, the SPN NanA mutant was transformed with empty vector control (pDC123), pNanA, or the deletion plasmids pNanAlect and pNanAenz, and grown in THY + 2 µg/ml chloramphenicol. L. lactis strain NZ9000 transformed with p E NanA or empty vector control (pDCerm) were grown in THB + erythromycin (5 µg/ml). Surface expression of proteins was confirmed using a rabbit polyclonal anti sera against NanA protein fragment (318-792), a fluorescent secondary anti body, and flow cytometry. After overnight incubation at 37°C, with 5% CO 2 , bacteria were reinoculated into fresh media, grown to midlogarithmic growth phase (OD600 nm = 0.4), centrifuged at 4,000 rpm for 5 min, washed once with PBS, and then resuspended in the appropriate buffer for use in the assays described inthe following paragraphs.
Generation of NanA expression plasmids. The NanA gene was am plified by PCR from the D39 chromosome using primers NanAUpF (5GATTGGAGAAAGGAGAGGGG3) and NanADownR (5CGT ATCAGCCTGAATGTCATC3), and the resulting amplicon direction ally cloned into plasmid pDCerm to yield the expression plasmid p E NanA for gainoffunction studies in L. lactis. The amplicon was also subcloned into pDC123, which is identical to pDCerm but bearing a chlorampheni col instead of erythromycin resistance marker, for complementation stud ies in the SPN NanA mutant. Critical active site residues of NanA were eliminated from p E NanA by inverse PCR using primers NanAenzUp (5TGTATTTTGCGCACGTCTATTGTTC3) and NanAenzDown (5GGTTGACTGGAGATCTTCAGGTTG3). Blunt end ligation of the amplicon deleted residues 645-662, including 2 amino acids critical for sialidase activity, and the modified, enzymedead NanA was subcloned into vector pDC123 to produce pNanAenz, an expression plasmid for comple mentation analysis using the NanA mutant. To eliminate the Nterminal lectinlike domain of NanA, a similar process of inverse PCR followed by blunt end ligation was performed on p E NanA using the primers NanAlecUp (5GGTTGAGCTCTCCCCCGAAAG3) and NanAlecDown (5ATG CCAGATGTAACGCATGTGCA3). Subcloning of the modified peptide into pDC123 yielded pNanAlec, an expression/complementation plasmid containing NanA with a deletion of residues 74-229.
Sialidase activity assay. A quantitative assay using 4Methylumbelliferyl Nacetyldneuraminic acid sodium salt hydrate (4MU; Fluka USA) was used to assay sialidase activity. SPN (WT D39 and isogenic NanA mutant) and L. lactis-expressing NanA constructs were centrifuged, washed once, re suspended in 100 µl 0.1M phosphate citrate buffer (pH 6.5) to 10 9 CFU/ml. Bacterial suspensions were sonicated (Sonic Dismembrator 550; Thermo Fisher Scientific) on ice for 5 s, followed by 15s rest intervals × 5 cycles. Sample aliquots of 50 µl were added to individuals wells of a 96well mi crotiter plate and mixed with 50 µl of 4MU diluted to 0.35% in phosphate citrate buffer. The plate was incubated at 37°C and fluorescence (excitation
